A View LCS vs eMurmur Heart AI
AI Verdict
Choose AVIEW LCS if…
Choose A View LCS if your primary need is a comprehensive, AI-powered analysis of thoracic CT scans for detailed anatomical assessment and quantification. This tool is ideal for lung cancer screening programs requiring automated nodule detection, volume quantification, and Lung-RADS scoring, as well as for quantifying emphysema and coronary artery calcification from a single low-dose CT. It provides in-depth radiological insights and automated reporting for complex thoracic conditions.
View AVIEW LCS →Choose eMurmur Heart AI if…
Choose eMurmur Heart AI if you require an efficient, non-invasive method for automated heart and lung sound analysis, particularly for screening and monitoring in primary care or telehealth settings. This platform is best suited for quickly detecting and classifying heart murmurs and other respiratory sounds, providing hemodynamic insights, and facilitating remote auscultation and longitudinal data comparison without the need for imaging. It offers a convenient, hardware-neutral solution for initial assessments and ongoing patient monitoring.
View eMurmur Heart AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AVIEW LCS | eMurmur Heart AI |
|---|---|---|
| Pricing | Subscription or one-off payment | Contact for quote |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | Web-based, Mobile App, API integration |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur Heart AIeMurmur Heart AI offers broad accessibility through its mobile app and web portal, coupled with hardware-neutral and stethoscope-agnostic compatibility. This provides superior ease of use for a wider range of healthcare professionals and settings, particularly in telehealth scenarios. A View LCS, while flexible in deployment, is primarily focused on a specialized imaging workflow.
Clinical Value
AVIEW LCSAVIEW LCS provides comprehensive, multi-disease analysis from a single low-dose CT scan, covering high-stakes conditions such as lung cancer screening, emphysema quantification, and coronary artery calcification. This depth and breadth of diagnostic information from one imaging study offer significant clinical impact. eMurmur Heart AI, while valuable for auscultation analysis, addresses a narrower scope of diagnostic insights.
Pricing & Value
TieBoth tools require direct contact for pricing information, indicating a lack of transparency. Without specific pricing details or publicly available case studies on return on investment, it is not possible to objectively compare their value propositions.
Enterprise Readiness
AVIEW LCSBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, which are foundational for enterprise readiness. However, AVIEW LCS provides a broader array of deployment options, including cloud, hybrid, local hardware, and virtualized solutions, offering greater flexibility for diverse enterprise IT infrastructures and data governance requirements.
Innovation
AVIEW LCSWhile both are innovative, AVIEW LCS's ability to perform comprehensive multi-disease analysis (lung cancer, emphysema, and coronary artery calcification) from a single low-dose CT scan, alongside its 'CT kernel conversion AI technology,' represents a more profound technological advancement in medical imaging analysis. eMurmur Heart AI's innovation lies more in the application of AI to auscultation for accessibility.
Support & Docs
TieBoth Coreline Soft and CSD Labs are established medical device companies that appear to offer standard professional support and documentation. Coreline Soft mentions 'Technical Support' and 'Customer Service', and CSD Labs provides a 'Support' section with contact forms and FAQs. However, without specific details on the scope, availability, or quality of their support services or documentation, it is not possible to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AVIEW LCS | eMurmur Heart AI |
|---|---|---|
| Name | A View LCS | eMurmur Heart AI |
| Company | Coreline Soft Co. | CSD Labs |
| Primary Function | AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. | AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. |
| Main Analysis Focus | Automated lung nodule detection and classification, Nodule volume quantification, Lung-RADS scoring, Emphysema analysis, Coronary Artery Calcium (CAC) scoring. | Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes), Detection and classification of pathologic and innocent heart murmurs, Hemodynamic insights. |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Internal Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring AVIEW LCS and eMurmur Heart AI.